Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480633 · ClinicalTrials.gov registry record
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
A clinical trial of Cardiovascular Risk Factor and Heart Failure With Reduced Ejection Fraction, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT03480633 is a study of Cardiovascular Risk Factor and Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 3,000 participants, roughly in line with the 2,971-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT03480633, a study of Cardiovascular Risk Factor and Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
In this single-center, longitudinal observational study, we will comprehensively examine clinical characteristics, proteomic, metabolomic, genomic and imaging data to better understand how different heart failure types may develop and progress over time. We will evaluate distinct sub-groups of heart failure (also known as heart failure phenotypes) and cardiomyopathies including amyloidosis with an ultimate goal of bringing the right medications and therapy to the right patients to optimize benefit and minimized side effects, an effort to improve precision medicine in heart failure.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2016-04-07 |
| Est. Completion | 2027-10-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03480633
The ClinicalTrials.gov registry entry for NCT03480633 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,971-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 0 interventions.
NCT03480633 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03480633 about?
NCT03480633 is a clinical study titled "Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure". In this single-center, longitudinal observational study, we will comprehensively examine clinical characteristics, proteomic, metabolomic, genomic and imaging data to better understand how different heart failure types may develop and progress over time. We will evaluate distinct sub-groups of heart...
What is the current status of trial NCT03480633?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2016-04-07. Estimated completion is 2027-10-06.
What conditions does trial NCT03480633 study?
This clinical trial studies the following conditions: Cardiovascular Risk Factor, Heart Failure With Reduced Ejection Fraction, Heart Failure With Normal Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Heart Failure, Right Sided.
Who is sponsoring clinical trial NCT03480633?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03480633 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Risk Factor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
Community Benefit of No-charge Calcium Score Screening Program
RECRUITING
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
Sleep Duration and Cardiovascular Health
RECRUITING · NA
-
The Potassium Supplementation Study
RECRUITING · NA
-
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
RECRUITING · NA
Explore more on PlainTrial
Cardiovascular Risk Factor
All registered trials for this condition
Heart Failure With Reduced Ejection Fraction
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.